Sign in

Dr. Jeffrey Millman

@jeffreymillman.bsky.social
1.9K followers 3.5K following 153 posts

Washington University School of Medicine Professor | Diabetes Researcher | Stem Cell Biologist | Bioengineer | Inventor | STEM Educator | Former MIT & Harvard | Former Biotech VP | sites.wustl.edu/millmanlab

PostsRepliesMedia
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 19/08/2026
Now Open: Submit Your Abstract for International Pancreas and Islet Transplant Association (IPITA) 2027 tracking.tts.org/campaign?d=l...
tracking.tts.org
Now Open: Submit Your Abstract for IPITA 2027
010
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 15/07/2026
🚨 New paper from our lab! How do stem cell-derived islets respond to hypoxia and how does that compare to primary islets? Using single-cell RNA-seq, functional assays, & metabolic profiling, we found that the two islet sources respond in different ways www.nature.com/articles/s41...
070
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 01/06/2026
🚨We have published our latest differentiation strategy for #stemcell derived islets. By depolymerizing F-actin at the beginning of differentiation, we enhanced β-cell formation, function, and safety for #diabetes cell therapy. 🧵below www.nature.com/articles/s41...
nature.com
Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation - Nature Communications
This study demonstrates that cytoskeletal state at the onset of directed differentiation impacts the exit of stem cells from pluripotency and downstream lineage specification. These findings are utili...
165
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 26/05/2026
🚨 New paper from our lab in BMC Methods! We describe a simple, rapid, and cost-effective method to identify subcutaneously transplanted pancreatic human islet grafts using dithizone (DTZ) staining. #diabetes #stemcells #islets 🧵 link.springer.com/article/10.1...
link.springer.com
Optimizing post-transplantation detection of subcutaneously transplanted islets using dithizone staining - BMC Methods
BMC Methods - Pancreatic islet transplantation is a promising therapeutic strategy to restore insulin independence in patients with type 1 diabetes mellitus. In addition to primary human islets,...
1101
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 20/05/2026
🚨Excited to share our single-cell multi-omic atlas of #stemcell islet differentiation that predicts cell fate decisions and identifies causal regulators of lineage specification. You can start browsing the data now 👉 synbioelab.com/islettwin Preprint 👉 www.biorxiv.org/content/10.6...
130
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 03/04/2026
From immigrating alone at 15 to pursuing a career in medicine - Check out the latest in our "Meet the Researcher" series. Tai Le is a post-bacc in my laboratory helping to develop a cure for diabetes endocrinology.wustl.edu/meet-the-res...
endocrinology.wustl.edu
Meet the Researcher: Tai Le
Tai Lee of Millman Lab Most 15-year-olds are figuring out who they want to be. Tai Le was doing that too – just 9,000 miles from home, on his own. At just 15, Le immigrated to the United States fro…
050
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 17/02/2026
新年快乐!
media.tenor.com
a chinese new year greeting card with fireworks and lanterns on a red background
ALT: a chinese new year greeting card with fireworks and lanterns on a red background
151
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 17/02/2026
Honored to be appointed the Alan A. and Edith L. Wolff Professor of Endocrinology at @washumedicine. Grateful to my colleagues, trainees, and collaborators helping us to advance stem cell-derived islet therapies toward transformative treatments for type 1 diabetes.
4101
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 22/01/2026
Excited to share our new publications working with Dr. Albert Kim. We developed a stem cell model of glioblastoma (GBM) and uncovered how INSM1 programs a progenitor network that fuels GBM progression www.nature.com/articles/s41...
nature.com
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model - Nature Communications
Glioblastoma (GBM) is characterized by a high degree of heterogeneity and plasticity due to interplay with neural developmental programs. Here, the authors develop a model of GBM by introducing sequen...
0111
Reposted by Dr. Jeffrey Millman
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 19/12/2025
(please share) Immediate #postdoc job opening in the Millman lab at WashU Med (St. Louis, MO). Want to develop next-generation pancreatic islets for the study and treatment of diabetes? Email your CV to apply sites.wustl.edu/millmanlab/
02319
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 19/12/2025
(please share) Immediate #postdoc job opening in the Millman lab at WashU Med (St. Louis, MO). Want to develop next-generation pancreatic islets for the study and treatment of diabetes? Email your CV to apply sites.wustl.edu/millmanlab/
02319
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 19/12/2025
Grateful to be celebrating this holiday season with these amazing scientists! We look forward to further advances in 2026! @WashUMedEndo @WashUDeptMed
090
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 17/12/2025
Dr. Veronese-Paniagua and I just published a review examining type 1 diabetes (T1D) as the consequence of genetic susceptibility and environmental viral exposures converging to drive autoimmune destruction of pancreatic β cells. Check it out here! www.frontiersin.org/journals/end...
frontiersin.org
Frontiers | The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the T cell-mediated destruction of insulin-secreting pancreatic β cells, leaving patie...
170
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 05/12/2025
Congratulations #MillmanLab Dr. Marlie Maestas for successfully defending her PhD!
040
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 31/10/2025
doing academic research right now
090
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 30/10/2025
🚀 Ready to launch your postdoc journey? Check out WashU’s new Postdoc Passport for everything you need to get started. Register for the virtual event December 4th. postdoc.wustl.edu/prospective-...
postdoc.wustl.edu
PASSPoRT to WashU | Office of Postdoctoral Affairs | Washington University in St. Louis
Pathways to Advanced Scientific Skills through Postdoctoral Research Training (PASSPoRT) Register Here Thank you for considering WashU for your...
011
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 23/10/2025
Our qPCR data is now protected by sharks!
1130
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 22/10/2025
Congratulations #MillmanLab member Dr. Veronese Paniagua for successfully defending his PhD yesterday!
010
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 20/10/2025
The #MillmanLab had a great time at the Breakthrough T1D walk yesterday! Happy to share our excitement for science with so many young people and support people living with #T1D!
010
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 13/10/2025
The #MillmanLab is excited to be part of Vendor Village at the St. Louis @BreakthroughT1D Walk Sunday October 19! Come visit us to learn more about our cutting-edge research into stem cell-derived therapies for type 1 #diabetes and how we’re working toward a future without T1D.
171
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 08/09/2025
The Millman Lab is proud to join the @BreakthroughT1D Walk in St. Louis on Oct 19 to support everyone living with type 1 diabetes. 🔗 Please consider donating to advance T1D research: www2.breakthrought1d.org/site/TR?fr_i...
www2.breakthrought1d.org
Join our Breakthrough T1D Walk team and help create a world without type 1 diabetes (T1D).
Our team is walking and raising funds to support the most promising, cutting-edge science to create a world without T1D. Join us!
161
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 02/09/2025
Out today in @cp-cellreports.bsky.social! We found that coxsackievirus B3 (CVB3), associated with increased risk of #T1D, infects all human pancreas cell types, not just beta cells. Great collab w/ Hubert Tse (KUMC). Led by WashU DBBS PhD student Daniel Veronese-Paniagua www.cell.com/cell-reports...
cell.com
Coxsackievirus B infection invokes unique cell-type-specific responses in primary human pancreatic islets
Veronese-Paniagua et al. demonstrate that coxsackievirus B3 infects all primary human islet cell types and elicits distinct cell-type-specific transcriptional and mitochondrial responses. They identif...
192
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 28/08/2025
[please retweet] I’m #hiring! The Millman Lab is looking for a postdoctoral researcher to lead an exciting new project focused on vascularized #stemcell-derived islets for #diabetes disease modeling and cell replacement therapy. Email me your CV and cover letter.
032
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 25/08/2025
Join us for the 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium. We have an amazing program this year focusing on type 1 #diabetes. We have also extended the abstract submission deadline to Sept 19. Register and submit your abstract a www.levinesymposium.com
011
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 11/08/2025
A few days ago marked my 10th anniversary as a faculty member at Washington University School of Medicine in St. Louis. I arrived in 2015 as an Assistant Professor, excited but nervous to start my own lab. Today, I’m a Full Professor, reflecting on an incredible decade. 🧵
2261
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 07/08/2025
New application note from R&D Systems showcases efficient, reproducible generation of iPSC-derived pancreatic islets based on our 2021 Nature Protocols paper. High purity (75–80% C-peptide+/NKX6.1+) & robust glucose-stimulated insulin secretion www.rndsystems.com/resources/li... #T1D
rndsystems.com
050
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 06/08/2025
I had the privilege to work with several experts in T1D as part of a June 2024 international Expert Forum at ADA organized by the editors of Diabetes, Diabetes Care, and Diabetologia to write a review article on T1D heterogeneity, check it out! diabetesjournals.org/diabetes/art...
diabetesjournals.org
The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum
This article summarizes the current understanding of the heterogeneity of type 1 diabetes from a June 2024 international Expert Forum organized by the edit
030
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 05/08/2025
New #diabetes publication in the NEJM. Sana Biotechnology provides evidence that gene-edited islets survive after transplantation into a patient without immunosuppressing drugs for several months www.nejm.org/doi/full/10....
nejm.org
Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression | NEJM
The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of genetically m...
0111
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 18/07/2025
When you say yes to just one more committee and now you're chairing it
010
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 09/07/2025
Meet Allison Kelley, a technician at WashU’s Millman Lab! A Biomedical Engineering grad from UMiami, she authored a new paper in Biotechnology & Bioengineering and is shaping her career at the intersection of science, medicine, and patent law #womeninSTEM sites.wustl.edu/millmanlab/p...
sites.wustl.edu
Meet the Researcher: Allison Kelley
By Erika Brown – July 7, 2025 Research Technicians are the backbone of research laboratories. They actively participate in various projects, acquiring knowledge that they can apply in their f…
1113
Reposted by Dr. Jeffrey Millman
Nate Huebsch @natehuebsch.bsky.social · 26/06/2025
Congratulations to @sydneal123.bsky.social‬ on publication of the main body of work from her PhD thesis, now out in the Journal of Biomedical Materials Research Part A! dx.doi.org/10.1002/jbm....
dx.doi.org
Enhancing the Potency of Growth Factor‐Mimicking Peptides via Cross‐Presentation With Integrin Ligands
Growth factors enhance survival and integration of transplanted Mesenchymal Stromal Cells (MSC), but successful supplementation often requires supraphysiological growth factor doses, risking off-targ....
131
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 23/06/2025
Big #T1D news! Vertex has published their phase 1–2 trial of stem cell-derived islets (VX880, now called zimislecel). All 12 full-dose patients had reduced insulin need, and 10 no longer require insulin injections. Major step forward to a functional cure! www.nejm.org/doi/full/10....
nejm.org
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...
0103
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 20/06/2025
Looking forward to chairing the #ADA2025 session "Innovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy" with many excellent speakers! Join us at 3:45p in room W196 BC.
051
Reposted by Dr. Jeffrey Millman
pankbase.bsky.social @pankbase.bsky.social · 10/06/2025
PanKbase #ADA2025 spotlight: PI @annagloyn.bsky.social presents Sun. the 22nd at 2pm CDT. Session: Genetic Regulation of Beta-Cell Mass and Function in Humans: Lessons from GWAS and Rare Genetics. Her talk: "Integrating Multiomic Data to Understand Complex Gene Regulatory Networks in Islets"
043
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 20/06/2025
Here at #ADA2025 in Chicago! Looking forward to learning about the latest research in diabetes and catching up with colleagues!
030
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 16/06/2025
Will Kodner, a former summer high school student trainee, has rejoined the Millman Lab to continue his training as he prepares to begin his freshman year at WashU in the fall. Welcome back, Will!
040
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 09/06/2025
Congrats to Millman Lab trainee Alice Smagorinsky on her selection for the 2025 @dkNET_Info Summer of Data Program! She'll sharpen her skills in data science, rigor & reproducibility, and data management over a 7-week immersive research experience.
020
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 29/05/2025
Per Breakthrough T1D: We appreciate Hoda Kotb for opening up about her daughter Hope’s T1D diagnosis. A T1D diagnosis has an impact on the whole family, and the adjustment can be difficult. Thank you, Hoda, for sharing your story and helping raise awareness www.breakthrought1d.org/t1d-resources/
030
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 19/05/2025
The RLM Postdoctoral Fellowship at WashU supports innovative, cross-disciplinary research with funding, mentorship, and a vibrant scientific community with non-federal funding Apply now: regenerativemedicine.wustl.edu/funding-2/rl... #StemCells #RegenerativeMedicine #PostdocOpportunity #WashU #Jobs
regenerativemedicine.wustl.edu
Rita Levi-Montalcini Postdoctoral Fellowship in Regenerative Medicine
Application Application window is now open. Due Date June 15th, 2025 – Current RFA details The Center of Regenerative Medicine (CRM) at WashU invites applications for the Rita Levi-Montalcini…
020
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 24/04/2025
NIDDK is celebrating its 75th anniversary this year by releasing a collection of articles highlighting the advances made. I am happy that I could contribute to one on advances in cell replacement therapy. Check it out! diabetesjournals.org/diabetes/art...
diabetesjournals.org
Advances in Cell Replacement Therapies for Diabetes
Islet cell replacement therapies have evolved as a viable treatment option for type 1 diabetes complicated by problematic hypoglycemia and glycemic labilit
171
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 22/04/2025
WashU is accepting applications for Postdoctoral Fellowship in Diabetes & Related Metabolic Diseases (T32 DK007120). If you are eligible for T32 support (need to be a US citizen or permanent resident) and are interested in working with stem cell-derived islets, please contact me!
166
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 14/04/2025
Millman Lab members and their families joined a cleanup in Wells-Goodfellow on Saturday for Earth Month. The event was part of an environmental justice series by earthday365 tackled illegal dumping and litter in underserved #StLouis neighborhoods.
070
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 02/04/2025
Important diabetes news. Unfortunately, while VX264 (Vertex's encapsulated stem cell derived islet product) has been safe in patients, the company has discontinued the trial due to insufficient function of the cells. investors.vrtx.com/news-release...
investors.vrtx.com
Vertex Announces Program Updates for Type 1 Diabetes Portfolio | Vertex Pharmaceuticals
The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
263
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 31/03/2025
WashU is pausing some construction projects (which provide jobs to people in Missouri), reducing the number of students admitted to some graduate programs, among other restrictions in response to the federal government. How is this improving the lives of voters in Missouri?
010
Reposted by Dr. Jeffrey Millman
Jonathan Rockoff @jonathanrockoff.bsky.social · 29/03/2025
Breaking: The FDA's top vaccine official was pushed out and resigned today from the agency, @lizessleywhyte.bsky.social reports
wsj.com
Exclusive | Top Vaccine Official Out at FDA
In his resignation letter, Dr. Peter Marks cited ‘misinformation and lies’ from Health and Human Services Secretary RFK Jr.
33934
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 14/03/2025
It finally happened. I received my first peer review that was clearly written by AI.
140
Reposted by Dr. Jeffrey Millman
Jing Hughes @jinghughes.bsky.social · 08/03/2025
This is as good an introduction as any - the reason why I am here. #StandUpForScience. Nice to see you all.
2193
Reposted by Dr. Jeffrey Millman
Alexandria Ocasio-Cortez @aoc.bsky.social · 26/02/2025
This vote was to start the process of the cuts. It WILL come back for a final vote. There are some chances to slow or potentially stop it. Need constant pressure on GOP Focus on GOP swing seats & key committees. Energy & Commerce is where the Medicaid fight will go down. Ways&Means for tax fight.
11604772212609
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 22/02/2025
Penn to reduce graduate admissions, rescind acceptances amid federal research funding cuts www.thedp.com/article/2025...
thedp.com
Penn to reduce graduate admissions, rescind acceptances amid federal research funding cuts
Penn notified department chairs that it will cut admissions across graduate programs — a decision faculty members say will force them to rescind offers from newly-accepted students.
135
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 16/02/2025
ARPA-H director removed by Trump administration www.fiercebiotech.com/research/dir...
fiercebiotech.com
ARPA-H director removed by Trump administration
Renee Wegrzyn, Ph.D., the inaugural head of the Advanced Research Projects Agency for Health (ARPA-H), has been let go, a Department of Health and Human Services spokesperson confirmed with Fierce | R...
000